Basic Body Awareness Therapy: The Basic Body Awareness Therapy program includes low-intensity physiotherapy exercises focused on awareness of contact with the floor, postural alignment, breathing-movement integration, weight transfer, trunk control, balance, and fluent movement quality.
Study summary
This interventional study will evaluate the effects of Basic Body Awareness Therapy (BBAT) on gait and plantar pressure outcomes in healthy young adults. Participants aged 18 to 25 years will receive a 12-week BBAT program delivered twice weekly by a physiotherapist trained in BBAT. Outcomes will be assessed at baseline, after the 12-week intervention, and at 3-month follow-up. The primary aim is to determine changes in gait speed and other spatiotemporal gait parameters during the 10-meter walk test. Secondary aims are to examine changes in static and dynamic plantar load distribution, right-left load sharing, and regional plantar pressure parameters. The study hypothesizes that BBAT will improve gait speed, reduce right-left differences in spatiotemporal gait parameters, improve bilateral load distribution during static stance and walking, and maintain these gains at 3-month follow-up.
Eligibility
Sex
ALL
Min age
18 Years
Max age
25 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Aged 18 to 25 years
* Able to walk independently
* No history of lower-extremity, spine, or balance-affecting trauma and/or surgery within the last 6 months
* Not receiving regular Basic Body Awareness Therapy
* Provides written informed consent
Exclusion Criteria:
* History of neurological, vestibular, or rheumatological disease
* Acute musculoskeletal injury
* Serious visual or hearing impairment
* Pain, deformity, or assistive device use that may affect walking performance
* Participation in a physiotherapy program and/or regular exercise program within the last 6 months
* Any condition preventing regular participation in assessment or therapy sessions
Primary outcome measure(s)
Change in Gait Speed — Baseline, after 12 weeks of intervention, and 3 months after intervention completion. Gait speed will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles. Participants will be instructed to walk at maximum walking speed on a 10-meter walkway. The best test performance will be used for analysis. The metric will be recorded in meters/second.
Change in Cadence — Baseline, after 12 weeks of intervention, and 3 months after intervention completion. Cadence will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Cadence will be recorded as the number of steps per minute.
Unit of Measure: steps/min
Change in Step Length — Baseline, after 12 weeks of intervention, and 3 months after intervention completion. Step length will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Step length will be recorded in meters.
Unit of Measure: m
Change in Step Time — Baseline, after 12 weeks of intervention, and 3 months after intervention completion. Step time will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Step time will be recorded in seconds.
Unit of Measure: s
Change in Stride Time — Baseline, after 12 weeks of intervention, and 3 months after intervention completion. Stride time will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Stride time will be recorded in seconds.
Unit of Measure: s
Change in Stance Phase Duration — Baseline, after 12 weeks of intervention, and 3 months after intervention completion. Stance phase duration will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Stance phase duration will be recorded as a percentage of the gait cycle.
Unit of Measure: %
Change in Swing Phase Duration — Baseline, after 12 weeks of intervention, and 3 months after intervention completion. Swing phase duration will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Swing phase duration will be recorded as a percentage of the gait cycle.
Unit of Measure: %
Change in Gait Asymmetry Index — Baseline, after 12 weeks of intervention, and 3 months after intervention completion. The asymmetry index for gait-phase timing parameters will be calculated using the formula:
AI = \[(Right - Left) / ((Right + Left)/2)\] × 100
The asymmetry index will be expressed as a percentage, with higher values indicating greater gait asymmetry.
Unit of Measure: %
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.